期刊文献+

子宫苗勒氏腺肉瘤临床病理特征分析 被引量:5

Clinicopathologic analysis of uterus mullerian adenosarcoma
下载PDF
导出
摘要 目的 探讨子宫苗勒氏腺肉瘤(uterine müllerian adenosarcoma,UMA)的临床病理特点,提高对UMA的诊断、鉴别诊断和治疗水平.方法 分析4例UMA的临床特点,肿瘤组织学形态特征及肿瘤免疫表型,并随访观察诊治结果及转归.结果 4例患者中3例发生于宫内膜,1例发生于宫颈.其中1例形态学为高级别腺肉瘤伴有横纹肌肉瘤异源性分化,并有肉瘤过度生长,手术后辅助化疗,2年半后肿瘤复发导致患者死亡;余3例中2例为低级别,1例为高级别,但术后均未进行放、化疗等抗肿瘤治疗,至今无复发.镜下所有病例均可见不规则囊性扩张或裂隙样腺体,肉瘤性间质以腺周袖套样(生发层)围绕腺体以及息肉样突入腺腔的形态学特征,肉瘤性间质核分裂像2~13个/10HPF.免疫表型:4例腺肉瘤上皮成分:CK、EMA均(+),其中宫内膜型上皮ER、PR、Vimentin均(+),CD10(-)、P53(-),Ki-67增殖指数低于5%.肉瘤性间质全部强阳性表达Vimentin,而ER、PR、SMA、Desmin、P53表达不一,Ki-67增殖指数3%~20%.结论 低级别腺肉瘤行子宫切除术后复发率较低,高级别腺肉瘤伴肉瘤过度生长者及伴有异源分化者复发快,预后较差。 Objective To analyze the clinicopathologic features of uterine mullerian adenosarcoma (UMA)in order to improve the diagnosis,differential diagnosis and therapy levels. Methods The clinical features, histological morphology and immunophenotyping of 4 patients with uterine mullerian adenosarcoma were retrospectively analyzed. Results 3 cases occurred in uterine endometrium and 1 cases occurred in cervix. 1 cases was uterine endometrial high -level adeno- sarcoma with heterogenous Rhabdomyosarcoma differentiation. Two and a half years after adjuvant chemotherapy after surgery, the patient died by recurrence. 3 cases were uterine endometrial low-grade adenosarcoma. The patients did not receive postoperative radiotherapy or chemotherapy and did no relapse so far. All cases were seen irregular cystic dilatation or crack-like glands and sarcoma of stromal Cuff-like glandular week (germinal layer) around the glands and glandu- lar polypoidhroke morphological characteristics. The sarcomatous component mitotic figures were 2- 13/10 HPF. 4cases of epithelial component of adenosarcoma were positive for CK and EMA. Endometrial epithelial were positive for ER,PR, vimenti, but negative for CD10 and p53. Ki-67 proliferation index of less than 5%. The sarcomatous component were strong positive for Vimentin, while the expression of ER, PR, SMA, Desmin, P53 were varies. Ki-67 proliferation index was 3-20%. Conclusion Low level adenosarcoma hysterectomy has a lower recurrence rate. The high level adenosarcoma with sarcoma and accompanied by an overgrowth of heterologous differentiation has a fast recurrence and poor prognosis.
出处 《西部医学》 2015年第5期726-729,732,共5页 Medical Journal of West China
关键词 子宫肿瘤 腺肉瘤 形态学 免疫表型 预后 Uterine neoplasms Adenosarcoma Morphology Immunophenotype Prognosis
  • 相关文献

参考文献8

  • 1Fleming NA, Hopkins I,de Nanassy J, et al. Mullerian adenosar- coma of the cervix in a 10-year-old girl: ease report and review ofthe literature[,J]. J Pediatr Adolese Gynecol,2009,22 : 45-51.
  • 2Tavassoli FA, Devilec P. World Health Organization classifica tionof tumors. Pathology and genetics, tumors of the breast an d femalegenital organs I-M]. Lyon.. IARC Press, 2003:245-249.
  • 3陈乐真.妇产科诊断病理学[M].北京:人民军医出版社,2010:115-116.
  • 4于静,朱慧庭.子宫Müllerian腺肉瘤七例子宫切除前后病理诊断的差异性分析[J].中华病理学杂志,2013,42(8):547-548. 被引量:2
  • 5Soslow RA, AliA,Oliva E. Mullerian ademosarcomas: an immu- nophenotypic analysis of 35 cases[J~. Am J Surg Pathol, 2008,32(7) : 1013-1021.
  • 6McCluggage WG. Mullerian adenosarcoma of the female genital tract[J]. Adv Anat Pathol, 2010, 17(2) : 122-129.
  • 7张安民,王啸,张兰仙.子宫Müllerian腺肉瘤伴肉瘤过度生长临床病理分析[J].临床与实验病理学杂志,2006,22(6):654-658. 被引量:9
  • 8谢冰,赵彦,沈丹华.子宫腺肉瘤一例报道及文献复习[J].中国妇产科临床杂志,2009,10(6):464-465. 被引量:3

二级参考文献34

  • 1Clement PB, Scully BE. Mullerian adenosareoma of the uterus. A clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol, 1990, 21: 363-381.
  • 2Manoharan M, Azmi MA, Soosay G, et al. Mullerian adenosarcoma of uterine cervix: Report of three cases and review of literature. Gynecologic Oncology, 2007, 105:256 - 260.
  • 3Clement PB, Scully RE. Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of Mullerian mixed tumor. Cancer, 1974, 34: 1138- 1152.
  • 4Tackin S, Bozaci EA, Sonmezer M, et al. Late recurrence of uterine Mullerian adenosarcoma as heterologous sarcoma: Three recurrences in 8 months increasing in number and grade of sarcomatous components. Gynecologic Oncology, 2006, 101 : 179-182.
  • 5ZaloudekCJ, Norris HJ. Adenofibroma and adenosarcoma of the uterus~ acbrucoparhologic study of 35 cases. Cancer, 1981, 48: 354-366.
  • 6Gast MJ, Radkins LV, Jacobs AJ, et al. Mullerian adenosareoma of the cervix with heterologous elements: diagnostic an s therapeutic approach. Gynecol Oneol, 1989, 32:381 - 384.
  • 7Maluf F, Sabbatini P, Schwartz L, et al. Endometrial stromal sarcoma : objective response to letrozole. Gynecol Oncol, 2001, 82: 384-388.
  • 8Amanta F, Gabrieib C, Moermanb P, et al. Immunohistochemical determination of hormone receptors in uterine adenosarcomas. Gynecologic Oncology, 2003, 88:463-464.
  • 9Smith DC, Macdonald OK, Gaffney DK. The impact of adjuvant radiation therapy on survival in women with uterine cardnosarcoma. Radiotherapy and Oncology, 2008, 88:227 - 232.
  • 10Baker TR, Steven Piver M, Lelle SB, et al. Stage I uterine adenosareoma: a report of six eases. J Surg Oneol, 1998, 37: 128- 132.

共引文献42

同被引文献17

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部